Status:
COMPLETED
Quality of Recovery Following Opioids Free Anaesthesia in Laparoscopic Sleeve Gastrectomy
Lead Sponsor:
Al Mashfa Medical Center
Conditions:
Narcotics
Recovery Quality
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Laparoscopic sleeve gastrectomy is widely employed nowadays. Multimodal analgesia approach is implemented within the enhanced recovery protocol in our facility to improve participants' recovery. Due t...
Eligibility Criteria
Inclusion
- 70 ASA II - III adult patients (18-60 years old)
- Elective laparoscopic bariatric surgery.
- Body mass index (BMI) is from 40 to 60
- Trocar sites at or above the umbilicus (T 10 dermatome).
Exclusion
- Allergy to amino-amide local anaesthetics,
- presence of coagulopathy
- local skin infection at injection sites,
- preoperative chronic dependence upon opioid and NSAID medications,
- liver or renal insufficiency,
- history of psychiatric or neurological disease, deafness,
- previous open surgery,
- patients who need to be converted to open surgery with more tissue trauma,
- ASA (American society of anesthesiologists) class above III were excluded.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04285255
Start Date
March 1 2020
End Date
August 1 2020
Last Update
November 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Mashfa medical center
Khobar, Eastern Provence, Saudi Arabia, 34225/7564